Cecchetti V, Fravolini A, Pagella P G, Savino A, Tabarrini O
Istituto di Chimica Farmaceutica e Tecnica Farmaceutica, Università di Perugia, Italy.
J Med Chem. 1993 Oct 29;36(22):3449-54. doi: 10.1021/jm00074a028.
A series of 2-substituted-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6 -carboxylic acids has been prepared and evaluated for in vitro antibacterial activity. These derivatives were less active than corresponding desmethylated analogues. Among these derivatives, the most active compound 22a was selected for preliminary pharmacokinetics in rats. The pharmacokinetic data indicated that 22a was rapidly absorbed and induced lasting plasma and urinary levels. In comparison with rufloxacin, it was excreted in low quantity in urine; a significant amount of desmethylated piperazinyl urinary metabolite was observed.
已制备了一系列2-取代-7-氧代-2,3-二氢-7H-吡啶并[1,2,3-de][1,4]苯并噻嗪-6-羧酸,并对其体外抗菌活性进行了评估。这些衍生物的活性低于相应的去甲基化类似物。在这些衍生物中,选择活性最高的化合物22a进行大鼠体内的初步药代动力学研究。药代动力学数据表明,22a吸收迅速,可使血浆和尿液中的药物水平持续存在。与芦氟沙星相比,其经尿液排泄的量较少;观察到有大量去甲基化的哌嗪基尿液代谢物。